202 related articles for article (PubMed ID: 38681125)
21. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
22. Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice.
Ma X; Zhou Z; Zhang X; Fan M; Hong Y; Feng Y; Dong Q; Diao H; Wang G
Cell Biol Toxicol; 2020 Oct; 36(5):509-515. PubMed ID: 32172331
[TBL] [Abstract][Full Text] [Related]
23.
Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
[TBL] [Abstract][Full Text] [Related]
24. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
25. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression.
Kong X; Zhang Y; Xiang L; You Y; Duan Y; Zhao Y; Li S; Wu R; Zhang J; Zhou L; Duan L
J Exp Clin Cancer Res; 2023 Sep; 42(1):236. PubMed ID: 37684625
[TBL] [Abstract][Full Text] [Related]
26. Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner.
Udayasuryan B; Zhou Z; Ahmad RN; Sobol P; Deng C; Nguyen TTD; Kodikalla S; Morrison R; Goswami I; Slade DJ; Verbridge SS; Lu C
Commun Biol; 2024 May; 7(1):551. PubMed ID: 38720110
[TBL] [Abstract][Full Text] [Related]
27. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
28. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of
Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X
Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607
[TBL] [Abstract][Full Text] [Related]
29. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
30. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.
Jiang SS; Xie YL; Xiao XY; Kang ZR; Lin XL; Zhang L; Li CS; Qian Y; Xu PP; Leng XX; Wang LW; Tu SP; Zhong M; Zhao G; Chen JX; Wang Z; Liu Q; Hong J; Chen HY; Chen YX; Fang JY
Cell Host Microbe; 2023 May; 31(5):781-797.e9. PubMed ID: 37130518
[TBL] [Abstract][Full Text] [Related]
31. Norepinephrine may promote the progression of
Du X; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Hu Q; Tian Q; Liang L; Zhao X; Li J; Zhao M; Fu X
Virulence; 2024 Dec; 15(1):2350904. PubMed ID: 38725098
[No Abstract] [Full Text] [Related]
32.
Wang N; Zhang L; Leng XX; Xie YL; Kang ZR; Zhao LC; Song LH; Zhou CB; Fang JY
Gut Microbes; 2024; 16(1):2333790. PubMed ID: 38533566
[TBL] [Abstract][Full Text] [Related]
33. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice.
Wang M; Li Y; Yang X; Liu Z; Wang K; Gong D; Li J
Immun Inflamm Dis; 2023 Nov; 11(11):e1067. PubMed ID: 38018574
[TBL] [Abstract][Full Text] [Related]
34. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development.
Zhao Y; Tao Q; Li S; Zheng P; Liu J; Liang X
Eur J Pharmacol; 2020 Dec; 888():173459. PubMed ID: 32768506
[TBL] [Abstract][Full Text] [Related]
35.
Chen S; Su T; Zhang Y; Lee A; He J; Ge Q; Wang L; Si J; Zhuo W; Wang L
Gut Microbes; 2020 May; 11(3):511-525. PubMed ID: 31910722
[TBL] [Abstract][Full Text] [Related]
36.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
37. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
38.
Kong C; Yan X; Zhu Y; Zhu H; Luo Y; Liu P; Ferrandon S; Kalady MF; Gao R; He J; Yin F; Qu X; Zheng J; Gao Y; Wei Q; Ma Y; Liu JY; Qin H
Cancer Res; 2021 Sep; 81(17):4485-4498. PubMed ID: 34162680
[TBL] [Abstract][Full Text] [Related]
39. Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer.
Gao Y; Zou T; Xu P; Wang Y; Jiang Y; Chen YX; Chen H; Hong J; Fang JY
Neoplasia; 2023 Jan; 35():100850. PubMed ID: 36371909
[TBL] [Abstract][Full Text] [Related]
40. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy.
Zheng DW; Dong X; Pan P; Chen KW; Fan JX; Cheng SX; Zhang XZ
Nat Biomed Eng; 2019 Sep; 3(9):717-728. PubMed ID: 31332342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]